Novo Nordisk Inc. recalls Wegovy (semaglutide) Injection
- Published
- 7 Jan 2026
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Presence of Particulate Matter: Hair was found in a prefilled syringe
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
- Brand / company
- Novo Nordisk Inc.
- Codes / lots
- Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027 | Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026
- Distribution
- Nationwide within the United States.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 7 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.